IRS Logo
Print - Click this link to Print this page

Qualifying Therapeutic Discovery Project Grants for the State of Colorado

OctoberThe listings below represent the applicants that have been awarded a Qualifying Therapeutic Discovery Program Grant.

The project descriptions below were extracted from the applicant certification forms as submitted.

 

Colorado $ 22,418,899.79
Applicant Name Project Name Grants Awarded for 2009 Grants Awarded for 2010
Accelr8 Technology Corporation BACcel Rapid Diagnostic $ 244,479.24  
Actium Biosystems, LLC Electromagnetic radio frequency excitation of nanoparticles for the external, non-invasive treatment of cancer via physical means.   $ 244,479.25
Allos Therapeutics, Inc Pralatrexate for the Treatment of Relapsed/Refractory Cutaneous T-cell Lyphoma (CTCL) $ 244,479.24  
Allos Therapeutics, Inc Pralatrexate for the Treatment of Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma (NHL) $ 244,479.24  
Allos Therapeutics, Inc Pralatrexate as treatment for urinary bladder trasitional cell carcinomas (TCCs). $ 244,479.24  
Allos Therapeutics, Inc Pralatrexate for the Treatment of Advanced Non-small Cell lung Cancer (NSCLC) $ 244,479.24  
Allos Therapeutics, Inc Pralatrexate for the Treatment of Advanced/Metastatic Breast Cancer $ 244,479.24  
Allos Therapeutics, Inc. Pralatrexate for the Treatment of Relapsed/Refractory Peripheral T-cell Lymphoma $ 244,479.24  
ApopLogic Pharmaceuticals, Inc AP-300 to treat superficial bladder cancer $ 105,313.00  
ApopLogic Pharmaceuticals, Inc. B201-acetate to treat small lung cancer and other hard to treat cancers $ 201,419.00 $ 3,032.50
Aqueous Biomedical Inc. Oculieve glaucoma shunt development $ 70,736.52 $ 155,000.00
ARCA Biopharma Inc Gencaro (Bucindolol) CHF Therapeutic $ 244,479.25  
ARCA biopharma, Inc NU172 Short-acting anticoagulant for cardiac procedures. $ 244,479.25  
ArcScan, Inc. Artemis 3 $ 244,479.25  
AspenBio Pharma Inc AppyScore™ $ 244,479.25  
Beacon Biotechnology LLC BrightSPOT diagnostic technology $ 180,126.83 $ 64,352.42
BioAMPS International, Inc Novel Therapeutics for the Treatment of Drug-resistant Bacterial Infections   $ 70,773.50
Biodesix Inc Mass Spectrometry for Prostate Cancer Detection $ 155,268.50 $ 89,210.75
BIODESIX INC Researching Immunosuppressive Agents for Improved EGFR-I Therapy Effectiveness $ 97,831.00 $ 146,648.25
Biodesix, Inc Mass Spectrometry for Diagnosis of Inflammatory Colitis $ 83,601.00 $ 118,757.50
BIODESIX, INC VeriStrat® : For Guiding Epidermal Growth Factor Receptor inhibitor Therapy in Cancer $ 244,479.25  
Biodesix, Inc Mass Spectrometry for Autoimmune Liver Disease Diagnosis $ 101,018.50 $ 118,757.50
Biodesix, Inc. CancerDetect:  For early diagnostic of lung cancer (LC) $ 162,120.00 $ 82,359.25
BiOptix Diagnostics, Inc. BiOptix Accolade Project $ 227,575.00 $ 16,904.25
Bolder Biotechnology Inc. Novel Erythropoiesis-Stimulating Protein for Chronic Kidney Disease and Cancer $ 41,763.53 $ 202,715.72
Bolder Biotechnology Inc. Novel, Long-Acting Growth Hormane Analog for Treatment Short Stature and Lipodystrophy $ 125,951.74 $ 118,527.51
Bolder Biotechnology Inc. Novel long-acting G-CSF analog for treating acute radiation syndrome and cancer $ 17,523.68 $ 196,704.31
Bolder Biotechnology Inc. Novel long-acting beta interferon analog for treating multiple sclerosis and cancer $ 119,991.28 $ 124,487.97
Bolder Biotechnology Inc. Novel, long-acting GM-CSF analog for treating acute radiation exposure and cancer-associated neutropenia. $ 21,682.98 $ 222,796.27
Cell Point EC Technology $ 244,479.24  
CeMines Inc Molecular Diagnostic Project for Lung Cancer $ 197,725.50  
Cerapedics Inc Peptide Enhancement Anorganic Bone Mineral for Cervical Spinal Fusion Surgery $ 244,479.24  
Cerapedics Inc Optimized Delivery Matrices for Augmenting Pluipotent {Stem} Cell Repair of Hard Tissue $ 244,479.24  
Cerapedics Inc Lyophilized Peptide Enhanced Bone Graft Conjugates For Trauma Applications $ 244,479.24  
CereScan Corp Development of tools to diagnose diseases and conditions of the brain $ 244,479.25  
Chata Biosystems, Inc A Stronger, Broad Spectrum, Environmentally safe Disinfectant $ 67,799.50 $ 176,679.75
Clovis Oncology Inc Development of CO-1.01 and companion diagnostic test for treatment of pancreatic cancer $ 244,479.25  
Clovis Oncology, Inc. Development of EMSI and companion diagnostic for treatment of non-small cell lung cancer   $ 244,479.25
Corgenix Medical Corporation Determination of predictive value of AtherOx for atherosclerotic cardiovascular disease. $ 26,250.00 $ 72,500.00
Crestone, Inc PoIC Inhibitors as Novel herapeutics for Antibiotic-Resistant Gram-Positive Infections $ 8,900.00 $ 138,840.00
Crestone, Inc. REP3123 as a Novel Therapeutic for Treatment of Clostridium difficile Infection $ 37,233.00 $ 60,885.00
EndoShape, Inc A nonmetalic, Shape Memory Polymer AAA Endograft to expand patient applicability, etc $ 130,608.00 $ 109,080.50
EndoShape, Inc An SMP fallopian tube occlusion device for non-surgical, permanent female sterilization, etc $ 61,230.00 $ 99,954.00
Eveia Medical,Inc Development of a Coagulation Test for Clinic and Home Use   $ 244,479.25
GlobeImmune, Inc. GI-6207 as active immunotherapy for the treatment of CEA over-expressing cancers. $ 241,869.50 $ 2,609.74
GlobeImmune, Inc. GI-4000 as active immunotherapy for the treatment of mutated-Ras cancers. $ 244,479.24  
Globelmmune, Inc. GI-5005 as active immunotherapy for the treatment of chronic hepatitis C virus infection $ 244,479.24  
Greffex, Inc Fully Deleted Helper-Virus Independent Vectors as Vaccine Carriers $ 244,479.24  
Hiberna Corporation Python Project $ 63,550.50 $ 33,591.50
ICVRX LLC CNS Site Specific Medication Delivery to Improve Outcomes for Refractory Epilepsy Patients   $ 244,479.25
Inviragen, Inc Recombinant attenuated chikungunya vaccine $ 113,013.50 $ 131,465.75
Inviragen, Inc A recombinant, tetravalent vaccine to prevent dengue fever $ 244,479.25  
Isogenis, Inc Protection of Tissue & Organ Transplants by Engineered Veto $ 244,479.24  
Kestrel Labs, Inc Noninvasive CO-Oximeter for Measuring Multiple Hemoglobin Species $ 244,479.25  
Lanx, Inc. Biomimetic Approach for the Delivery of Bone Morphogenic Proteins $ 119,000.00 $ 125,479.25
Leap Frogg, LLC Frogg Dynamic Compression system (FDCS) $ 189,969.50 $ 54,509.75
MBC Pharma Inc Novel bone-targeted therapeutics for cancer-induced bone disease $ 244,479.24  
Micro-Imaging Solutions LLC Rigid and Articulating-tipped (flexible), disposable CMOS-based endoscopes $ 244,479.24  
MicroPhage Inc Deveolpment of a Novel Rapid MRSA/MSSA Blood Culture Test $ 244,479.24  
MicroPhage, Inc Development of a Novel and Rapid Skin Tissue Antobiotic Susceptibility Test $ 244,479.24  
Miragen Therapeutics, Inc. Developing microRNA based therapies to transform the course of Cardiovascular Disease $ 244,479.25  
Myocept, Inc Myocept Project $ 78,224.16 $ 166,255.09
N30 Pharmaceuticals, LLC Inhibitors of S-nitrosoglutathione reductase (GSNOR)   $ 244,479.24
Ocutronics, LLC OC100 $ 76,411.00 $ 168,068.25
Otologics, LLC Carina Project $ 244,479.25  
Parascript, LLC AccuDetect $ 244,479.25  
PARE Surgical, Inc. Flexible Endoscopic Instruments $ 127,457.00 $ 117,022.24
Pathogen Systems, Inc. Pathogenic Microbe Detection Device $ 244,479.25  
PharmaJet Inc Novel Delivery of Drugs and Vaccines Enabled by Intradermal Jet Injection Technology $ 91,876.26 $ 152,602.99
Precision Photonics Corp Point-of-care(POC) diagnostic device for critical infectious disease panel testing $ 244,479.24  
ProFoldRx, Inc dba BaroFold, Inc High Pressure Refolding of protein Aggregates for Novel Therapeutics and Biosimilars   $ 244,479.25
Protectstyle Corporation Preventative Therapeutic Antimicrobial Textiles   $ 244,479.24
Pyxant Labs Inc LC/MSMS Bioassay for Physiologic Iron Biomarkers   $ 27,703.45
Pyxant Labs, Inc Trastuzumab Bioanalytical Assay for Regulatory Development Studies   $ 71,029.59
Quest Product Development Corporation Cardiac Sync Technology for Improved CPR Therapy $ 244,479.25  
Quest Product Development Corportaion MicroFlex Endescopes for Improved Diagnosis and Surgery $ 244,479.25  
Rocky Mountain Biosystems, Inc. Adtivated Thermoset Adhesive for Wound Closure $ 244,479.25  
Rocky Mountain Biosystems, Inc. Skin Patch for Drug Delivery after Controlled Stratum Corneum Ablation. $ 29,281.00 $ 73,049.00
Somalogic Inc A Simple Blood Test for the Early Detection of Mesothelioma $ 130,028.00 $ 114,451.25
SomaLogic, Inc A Simple and inexpensive Blood Test for the Early Detection of Non-Small Cell Lung Cancer $ 244,479.25  
SomaLogic, Inc Novel Therapeutics for the Treatment of Cancer $ 244,479.25  
SomaLogic, Inc A Simple and inexpensive Blood Test for the Early Detection of Ovarian Cancer $ 244,479.25  
SomaLogic, Inc. A Simple Blood Test for the Early Detection of Pancreatic Cancer $ 875.00 $ 193,137.00
SomaLogic, Inc. Novel Neuroprotective and Neuroregenerative Therapeutics for Neurodegenerative Diseases $ 244,479.25  
SomaLogic,Inc. Aggregation of Blood Test for Multiple Diseases into an Inexpensive Multiplexed Diagnostic $ 244,479.25  
SomaLogic. Inc A Simple and Inexpensive Blood Test for the Early Detection of Chronic Kidney Disease $ 86,685.50 $ 157,793.75
Sophono Inc Sophono Alpha 1 magnetic hearing prosthesis $ 82,120.82 $ 162,358.43
Source Precision Medicine Inc dba Source MDx Develop & Validate a Breast Cancer Early Detection Molecular Diagnostic Test $ 38,836.00 $ 205,643.25
Source Precision Medicine Inc dba Source MDx Develop & Validate a Molecular Diagnostic Test Predictive of Prostate Biopsy Outcomes $ 244,479.25  
Source Precision Medicine Inc dba Source MDx Develop & Validate a Lung Cancer Early Detectin Molecular Diagnostic Test $ 244,479.25  
St Cardio Technologies Z6 Cardiac Stimulator $ 186,138.50 $ 58,340.75
St. Renatus LLC Nasal Mist Dental Anesthetic $ 244,479.25  
Sundance Diagnostics, Inc Whole Genome Sequencing for Diagnostic Test for Suicidal Ideation $ 244,479.25  
Surefire Medical, Inc Paladin Embolization Infusion System $ 12,576.00 $ 231,903.25
ValveXchange, Inc Vitality ™ and Vanguard ™ heart valve systems $ 244,479.24  
Ventria Bioscience Development of an oral delivery platform biologics $ 111,500.00 $ 71,000.00
Ventria Bioscience Prevention of Antibiotic Associated Diarrhea $ 33,938.50 $ 210,540.75
Ventria Bioscience Treatment for spontaneous bacterial peritonitis $ 244,479.25  
Vitrolife Inc HELP- Human Ex-Vivo Lung Preservation and Reconditioning $ 244,479.24  
Page Last Reviewed or Updated: 09-Apr-2014